News Sentiment

VIVS sentiment intelligence

VivoSim Labs, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.58 Week of 17 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-34.1% over one week, -47.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

VIVS|VivoSim Labs Ord Shs|Price:0.446|Chg%:-0.015

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -34.1% Price reacting lower
Trend fit Trend inactive -47.4% over four weeks
Fair value -91.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 33
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
TradingView 6
Quiver Quantitative 5
MT Newswires 3
GlobeNewswire 2
InvestorsHub 2
Sahm 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 21
Guidance 3
Deals and strategy 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-50 of 50
KTVB Direct company coverage

VivoSim: Fiscal Q4 Earnings Snapshot

VivoSim Labs, Inc. (VIVS) reported a fiscal fourth-quarter net loss of $5.8 million, or $2.21 per share, with revenues of $40,000. For the full year, the company's loss totaled $13.8 million, or $5.35 per share, on revenues of $131,000. VivoSim Labs is a development-stage company

Tone
Negative 19/100
Event
Earnings
Published
14 Jul 2026 21:10
Source
KTVB
GlobeNewswire Direct company coverage

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting

VivoSim Labs, Inc. announced that data from its advanced 3D human tissue models will be featured at the European Society of Toxicology’s annual conference. The data demonstrate the superior predictive power of VivoSim's AI-enabled NAMkind™ Liver and NAMkind™ GI platforms for live

Tone
Positive 82/100
Event
Market update
Published
30 Jun 2026 07:09
Source
GlobeNewswire
Moomoo Direct company coverage

VivoSim Labs(VIVS) Stock Options Chain | Quotes & News

This article provides financial information for VivoSim Labs (VIVS), including its stock options chain, quotes, and related news. It serves as a portal for investors to access relevant market data for the company.

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 07:09
Source
Moomoo
TradingView Direct company coverage

Enterprise value to EBIT forward of VivoSim Labs, Inc. – NASDAQ:VIVS

This article provides financial context for VivoSim Labs, Inc. (NASDAQ:VIVS) by focusing on its enterprise value to EBIT forward metric. It appears to be a stub or partial financial data point from TradingView, indicating no specific value or further details beyond the title. The

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 23:09
Source
TradingView
TradingView Direct company coverage

Price to sales forward of VivoSim Labs, Inc. – NASDAQ:VIVS

This article provides financial information for VivoSim Labs, Inc. (NASDAQ: VIVS), specifically focusing on its price-to-sales forward metric. It appears to be a financial snapshot from TradingView, offering a quick look at the company's valuation.

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 07:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of VivoSim Labs, Inc. – NASDAQ:VIVS

The article provides a financial metric, "Enterprise value to revenue forward," for VivoSim Labs, Inc. (NASDAQ: VIVS). It states that the market for VivoSim Labs, Inc. is currently closed with no trades. The content is presented within the context of TradingView's financial analy

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 08:41
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of VivoSim Labs, Inc. – NASDAQ:VIVS

This article focuses on the "Price to earnings forward" financial metric for VivoSim Labs, Inc. (NASDAQ: VIVS), as presented on TradingView. It appears to be a financial data page rather than a traditional article, providing a snapshot of a specific financial ratio for the compan

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 07:10
Source
TradingView
timothysykes.com Direct company coverage

VivoSim Labs Stock Soars After Major Distribution Deals in Asia

VivoSim Labs Inc. (VIVS) stock surged by 82% after securing distribution agreements with JCBio in South Korea and Tekon Biotech in China for its NAMKind toxicology services. This strategic expansion into Asian markets aims to accelerate revenue growth, despite the company's curre

Tone
Positive 69/100
Event
Earnings
Published
14 Jun 2026 11:41
Source
timothysykes.com